
1. semin liver dis. 2010 aug;30(3):296-301. doi: 10.1055/s-0030-1262515. epub 2010
jul 21.

a patient chronic hepatitis b regression fibrosis treatment.

chang cy(1), martin p, fotiadu a, hytiroglou p.

author information: 
(1)division liver diseases, recanati/miller transplantation institute, the
mount sinai medical center, new york, ny 10001, usa.

we present patient hbeag-negative chronic hepatitis b, significant
regression hepatic fibrosis achieved lengthy antiviral treatment. 
a liver biopsy specimen obtained initiation treatment showed chronic
hepatitis b mild activity (histologic activity index: 7) marked fibrosis
(stage 4, scale 0 6). second biopsy specimen, obtained 10 years
later, demonstrated almost complete resolution necroinflammatory activity 
fibrosis. one year second biopsy, seroconversion hbsag positive to
anti-hbs positive status achieved, antiviral treatment discontinued. 
this case illustrative significant histologic improvement be
accomplished chronic hepatitis b viral activity suppressed long term. 
lengthy antiviral treatment achieve resorption excess fibrous tissue, even
in patients marked fibrosis.

copyright thieme medical publishers.

doi: 10.1055/s-0030-1262515 
pmid: 20665381  [indexed medline]

